MD Anderson Researchers Present Cellular Therapy Advances at the 2022 ASCO Annual Meeting
June 07, 2022
June 07, 2022
HOUSTON, Texas, June 7 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Highlights include three-year data from ZUMA-2, gamma delta CAR T cell therapy and NK cell combination treatment
* * *
Promising clinical results with cellular therapies for patients with blood cancers highlight advances being presented by researchers from The University of Texas MD Anderson Cancer Center at the 2 . . .
* * *
Highlights include three-year data from ZUMA-2, gamma delta CAR T cell therapy and NK cell combination treatment
* * *
Promising clinical results with cellular therapies for patients with blood cancers highlight advances being presented by researchers from The University of Texas MD Anderson Cancer Center at the 2 . . .